<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Korner, Germaine</dc:creator>
  <dc:creator>Noain, Daniela</dc:creator>
  <dc:creator>Ying, Ming</dc:creator>
  <dc:creator>Hole, Magnus</dc:creator>
  <dc:creator>Flydal, Marte I.</dc:creator>
  <dc:creator>Scherer, Tanja</dc:creator>
  <dc:creator>Allegri, Gabriella</dc:creator>
  <dc:creator>Rassi, Anahita</dc:creator>
  <dc:creator>Fingerhut, Ralph</dc:creator>
  <dc:creator>Becu-Villalobos, Damasia</dc:creator>
  <dc:creator>Pillai, Samyuktha</dc:creator>
  <dc:creator>Wueest, Stephan</dc:creator>
  <dc:creator>Konrad, Daniel</dc:creator>
  <dc:creator>Lauber-Biason, Anna</dc:creator>
  <dc:creator>Baumann, Christian R.</dc:creator>
  <dc:creator>Bindoff, Laurence A.</dc:creator>
  <dc:creator>Martinez, Aurora</dc:creator>
  <dc:creator>Thöny, Beat</dc:creator>
  <dc:date>2015-10-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Tyrosine hydroxylase catalyses the hydroxylation of L-tyrosine to l-DOPA, the rate- limiting step in the synthesis of catecholamines. Mutations in the TH gene encoding  tyrosine hydroxylase are associated with the autosomal recessive disorder tyrosine  hydroxylase deficiency, which manifests phenotypes varying from infantile  parkinsonism and DOPA-responsive dystonia, also termed type A, to complex  encephalopathy with perinatal onset, termed type B. We generated homozygous Th  knock-in mice with the mutation Th-p.R203H, equivalent to the most recurrent human  mutation associated with type B tyrosine hydroxylase deficiency (TH-p.R233H), often  unresponsive to l-DOPA treatment. The Th knock-in mice showed normal survival and  food intake, but hypotension, hypokinesia, reduced motor coordination, wide-based  gate and catalepsy. This phenotype was associated with a gradual loss of central  catecholamines and the serious manifestations of motor impairment presented diurnal  fluctuation but did not improve with standard l-DOPA treatment. The mutant tyrosine  hydroxylase enzyme was unstable and exhibited deficient stabilization by  catecholamines, leading to decline of brain tyrosine hydroxylase-immunoreactivity in  the Th knock-in mice. In fact the substantia nigra presented an almost normal level of  mutant tyrosine hydroxylase protein but distinct absence of the enzyme was observed  in the striatum, indicating a mutation-associated mislocalization of tyrosine  hydroxylase in the nigrostriatal pathway. This hypomorphic mouse model thus  provides understanding on pathomechanisms in type B tyrosine hydroxylase  deficiency and a platform for the evaluation of novel therapeutics for movement  disorders with loss of dopaminergic input to the striatum.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/304659</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/304659/files/awv224.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1093/brain/awv224</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Brain. - 2015, vol. 138, no. 10, p. 2948-2963</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
